Aachen, 19th November 2015. Steffen Fritzsche (51) has been Head of Corporate Communications at Grünenthal since 1st November 2015. In this position he supports the Corporate Executive Board in internal and external communications regarding all matters of corporate interest. He succeeds Friederike Herrfurth, who left the company at her own request.
Steffen Fritzsche previously worked for UCB Pharma in Monheim, where he set up and developed the Central European area as Head of Corporate Communications & Public Affairs from 2010 onwards. He has more than 20 years of national and international experience in pharma communications and stakeholder management, most of which he gained whilst working as a consultant for pharmaceutical companies. Steffen Fritzsche will report to Heinz-Gerd Suelmann, Head of Global Human Resources.
The Grünenthal Group is an independent, family-owned, international research-based pharmaceutical company headquartered in Aachen, Germany. We are an entrepreneurial specialist delivering true benefits to patients. By sustainably investing in research and development above the industrial average, we are committing to innovation in order to treat unmet medical needs and bring value-adding products to markets. Grünenthal is a fully integrated research & development company with a long track record of bringing innovative pain treatments and state-of-the-art technologies to patients. Altogether, the Grünenthal Group is present in 32 countries with affiliates in Europe, Australia, Latin America and the US. Grünenthal products are sold in more than 155 countries and approx. 5,300 employees are working for the Grünenthal Group worldwide. In 2014, Grünenthal achieved revenues of € 1.154 bn.
More information: www.grunenthal.com.
Head Corporate Communications
Phone +49 241 569-1568